In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Completed strategic review to focus on oncology and liver diseases with the acquisition of global rights to GB3226 (formerly BRM-1420), a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets ...

Karen Winkfield, MD, PhD, addresses the importance of meeting patients where they are to expand clinical trial participation ...

An overwhelming majority of Australians struggling with their mental health are turning to social media – not trained ...

Net research and development expenses for the device division increased in 2024 to CAD175,000 from CAD44,000 in 2023, a 400% increase. The increase is attributed to development of a new software ...

InformedDNA®, a precision health company revolutionizing the application of genomic insights, today announced the acquisition of Coriell Life Sciences, a provider of pharmacogenomic services and ...

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...

Interest in clinical trials is high, but barriers like cost and lack of doctor communication hinder participation. Survey shows patient eagerness.

The National Comprehensive Cancer Network® (NCCN®) has released a free, on-demand webinar titled “Why Should I Consider a ...

Columbia researchers believe their grants are being cut because of diversity components that were imposed by the federal ...

As NUCATS continues to champion translational research, grants like the Giddan Award ensure that pediatric health research ...

Researchers funded by the US National Institutes of Health are bracing for the worst, after rumours circulated that the ...